These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 18987300

  • 1. Health-related quality of life and hemoglobin levels in chronic kidney disease patients.
    Finkelstein FO, Story K, Firanek C, Mendelssohn D, Barre P, Takano T, Soroka S, Mujais S.
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):33-8. PubMed ID: 18987300
    [Abstract] [Full Text] [Related]

  • 2. Are there implications from the Trial to Reduce Cardiovascular Events with Aranesp Therapy study for anemia management in dialysis patients?
    Berns JS.
    Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):567-72. PubMed ID: 20601876
    [Abstract] [Full Text] [Related]

  • 3. Association of anemia correction with health related quality of life in patients not on dialysis.
    Alexander M, Kewalramani R, Agodoa I, Globe D.
    Curr Med Res Opin; 2007 Dec; 23(12):2997-3008. PubMed ID: 17958944
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. An expert opinion on the current treatment of anemia in patients with kidney disease.
    Locatelli F, Del Vecchio L.
    Expert Opin Pharmacother; 2012 Mar; 13(4):495-503. PubMed ID: 22296648
    [Abstract] [Full Text] [Related]

  • 9. Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa.
    Lefebvre P, Vekeman F, Sarokhan B, Enny C, Provenzano R, Cremieux PY.
    Curr Med Res Opin; 2006 Oct; 22(10):1929-37. PubMed ID: 17022852
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now?
    Singh AK.
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S5-13. PubMed ID: 19010260
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Attitude of physicians in Saudi Arabia towards anemia treatment strategies in patients with chronic kidney disease.
    Souqiyyeh MZ, Shaheen FA.
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):65-72. PubMed ID: 17237894
    [Abstract] [Full Text] [Related]

  • 20. It's time to compare anemia management strategies in hemodialysis.
    Coyne DW.
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):740-2. PubMed ID: 20299363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.